US FDA To allow Release of 300,000 Cans of EleCare Infant Formula By Abbott


The Food and Drug Administration (FDA) of the United States said, it is going to allow the release of around 300,000 cans of the EleCare infant formula based on amino acid by the Abbott Laboratories. The formula had been previously produced at the Sturgis facility of the company based in Michigan, and the regulator said that, it is going to be released to the individuals that need urgent and life-sustaining supplies on the basis of case-by-case.

In the month of February 2022, the company has recalled some baby formulas including the Similac and has also closed the company’s manufacturing plant in the region of Sturgis, along with creating one of the biggest infant formula shortages in the recent history for the families in the United States.

The biggest supplier of the powder baby formula of the United States has closed the facility after the reports of the bacterial infections among four infants and it has now exacerbated a shortage among the multiple producers of the baby formula that has been started with the issues of supply chain related to the novel corona virus pandemic.

See also  Trivitron Healthcare Acquired the Kennedy Healthcare Based in USA

US FDA said that, the agency has informed the Kendal Nutricare of the United Kingdom that, the agency has been exercising the enforcement discretion for the import of the certain infant formula under the brand known as Kendamil. The US regulator also said, the company is initially expecting around 2 million cans to land on the store shelves of the United States starting in the month of June 2022.


Writing is a medium to express feelings and convey facts. A creative mind never rests in peace and this amazing platform gives me the freedom to write about what I like most.

I’ve been a writer/blogger for the last twelve years and have covered technology-related topics. However, I also have considerable years of experience in writing for various domains – Technology, Beauty, Fashion, Pharmaceutical, human psychology etc. Technology is my forte.

I’ve handled many interesting projects. Writing is my passion. As an author, I’ve learned a lot in my long journey of penning down my thoughts!

See also  US Study: No Association Between Risk of Alzheimer’s Disease and Inflammatory Disease